HCPCS Level II · retired code
Q0174 — Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q0174 was retired on Dec 31, 2025
CMS ended Q0174 after Dec 31, 2025. Don’t report it for later dates of service. Look up the drug for its current code.
Code
CMS HCPCS fileHCPCS codeQ0174
Billing unit10 mg
- Descriptor
- Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Short descriptor
- Thiethylperazine maleate10mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2026
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Find the NDC
Med-Code hasn’t mapped Q0174 to specific products yet. Search the FDA NDC Directory for the drug named in the descriptor, and check the route and strength match the code.
Q0174: common questions
- Is Q0174 a CPT code?
- No. Q0174 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What is one billing unit of Q0174?
- One unit of Q0174 is 10 mg, as stated in the code's descriptor. Units to report = dose given ÷ 10 mg. J-code billing units.